Entera Bio (ENTX) EPS (Basic) (2019 - 2026)
Entera Bio (ENTX) posted quarterly EPS (Basic) of -$0.08 for Q1 2026, down 25.23% year-on-year from -$0.1 in Q1 2025, and up 99.64% on a QoQ basis from -$20.96 in Q4 2025.
Entera Bio (ENTX) EPS (Basic) (2019 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported EPS (Basic) for 8 consecutive years, with -$0.08 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) fell 25.23% year-over-year to -$0.08 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.27 (down 12.42% YoY) and the FY2025 annual result came in at -$76.41, down 30053.62% from the prior year.
- EPS (Basic) improved to -$0.08 in Q1 2026 per ENTX's latest filing, from -$20.96 in the prior quarter.
- Over the last five years, EPS (Basic) for ENTX reached as high as -$0.06 in Q1 2024 and fell as low as -$20.96 in Q4 2025.
- A 5-year average of -$1.31 and a median of -$0.08 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) jumped 42.14% — and 2025, when it plunged 33369.9%.
- Year by year, EPS (Basic) stood at -$0.11 in 2022, then surged by 34.72% to -$0.07 in 2023, then gained by 8.94% to -$0.06 in 2024, then tumbled by 33369.9% to -$20.96 in 2025, then jumped by 99.64% to -$0.08 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.08, -$20.96, and -$0.07 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | 0.00 |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -2.29 |
| 10 | Entera Bio | 187.21 Mn | 183.07 Mn | - | -0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | -20.96 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.06 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.13 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.11 |
| Jun 30, 2021 | -0.10 |